NB-001

· Nobias Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for NB-001, covering 2008-05-30 to 2025-02-10. Get the full timeline:

Most recent: Clinical Trial Update: NB-001 in Children and Adolescents With 22q11 Deletion Syndrome [Phase 2]